🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 759.97 -0.5% NASDAQ 100: 704.40 0.0% Dow Jones: 534.08 -0.5%

Bli - Banque De Luxembourg Investments - Q1 2026 13F Filings

BL

Bli - Banque De Luxembourg Investments

CIK: 0002052594
Address: Luxembourg Luxembourg City 16, Boulevard Royal
$3.34 B
Portfolio Value
175
Assets Held
Reporting Period: Q1 2026
Filing Status:
Active
Last Updated: 08/10/2026

Portfolio Summary (Q1 2026)

View Full Portfolio Analysis

Top Buys

Q1 2026
1. AZN Astrazeneca PLC
+$68.99 M

Top Sells

Q1 2026
1. ZTS Zoetis
−$41.56 M
2. ZBRA Zebra Technologies Corporation
−$15.76 M
3. XYL Xylem
−$12.39 M
4. YUMC Yum China Holdings
−$9.49 M

Asset Allocation

Stocks/ETFs
-1.98%
$3.34 B 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Bli - Banque De Luxembourg Investments Q1 2026 Filing Summary

Bli - Banque De Luxembourg Investments filed its 13F report for Q1 2026 on May 15, 2026. The portfolio totaled 3.34 B reflecting a -1.98% change from the prior quarter, spanning 175 assets. The top 10 holdings comprised 33.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 4 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Bli - Banque De Luxembourg Investments’s Q1 2026 Filing

Bli - Banque De Luxembourg Investments submitted their Form 13F-HR for the Q1 2026 period on 05/15/2026. This was the only submission for the quarter.

In the Q1 2026 filing, Bli - Banque De Luxembourg Investments reported a managed portfolio value of 3.34 B, consisting of 175 individual positions.

This page displays the raw filing documents. To see which stocks Bli - Banque De Luxembourg Investments bought or sold during Q1 2026, please visit Bli - Banque De Luxembourg Investments's Portfolio Analysis page.